Ronan MacLoughlinDr Ronan MacLoughlin is Director R&D, Science & Emerging Technologies, at Aerogen, an Irish medical device company specialising in Respiratory Drug Delivery. He is a former head of Medical Affairs, with responsibility for >45 investigator-initiated tials. With more than 20 years' experience in the design and
development of drug delivery systems and drug device combinations, he has >220 collaborative publications,
as well as 12 granted patents.

His most recent focus has been on enabling several clinical programs making use of aerosolised prophylactics
and therapeutics for COVID-19, and his work on delivery of inhaled vaccines has resulted in the
world's first approval for an orally inhaled vaccine for COVID-19 (Convidecia Air). His contribution to the
state of the art in fugitive medical and patient-derived aerosols was central to the evolution of several
critical care consensus statements around the safe use of aerosol therapy during the COVID-19 pandemic. Read More Read Less